Cargando…

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches

High-grade serous epithelial ovarian cancer (HGSC) is the most aggressive subtype of epithelial ovarian cancer. The identification of germline and somatic mutations along with genomic information unveiled by The Cancer Genome Atlas (TCGA) and other studies has laid the foundation for establishing pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zakarya, Razia, Howell, Viive M., Colvin, Emily K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370285/ https://www.ncbi.nlm.nih.gov/pubmed/32645943 http://dx.doi.org/10.3390/ijms21134806

Ejemplares similares

The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015)

Why the dual origins of high grade serous ovarian cancer matter
por: Colvin, Emily K., et al.
Publicado: (2020)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

Expression of long noncoding RNAs in cancer‐associated fibroblasts linked to patient survival in ovarian cancer
por: Colvin, Emily K., et al.
Publicado: (2020)

Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
por: Vafaee, Fatemeh, et al.
Publicado: (2017)

Culture Models to Define Key Mediators of Cancer Matrix Remodeling
por: Fuller, Emily Suzanne, et al.
Publicado: (2014)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
por: Colvin, Emily K., et al.
Publicado: (2022)

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
por: Kan, Casina WS, et al.
Publicado: (2012)

Epigenetic impacts of maternal tobacco and e-vapour exposure on the offspring lung
por: Zakarya, Razia, et al.
Publicado: (2019)

The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
por: Li, Xiaoduan, et al.
Publicado: (2017)

Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer
por: Colvin, Emily K.
Publicado: (2014)

Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments
por: Lokadasan, Rajitha, et al.
Publicado: (2016)

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
por: Gien, Lilian T., et al.
Publicado: (2010)

The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer
por: Nahm, Christopher B., et al.
Publicado: (2022)

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
por: Moran-Jones, Kim, et al.
Publicado: (2015)

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
por: Cornelison, Robert, et al.
Publicado: (2017)

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
por: Dumont, Sander, et al.
Publicado: (2019)

Mouse models of epithelial ovarian cancer for preclinical studies
por: Karakashev, Sergey, et al.
Publicado: (2021)

Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration
por: Pham, Binh T. T., et al.
Publicado: (2018)

Emerging and Evolving Ovarian Cancer Animal Models
por: Bobbs, Alexander S, et al.
Publicado: (2015)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

The detection, treatment, and biology of epithelial ovarian cancer
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

Immunotherapy Advances for Epithelial Ovarian Cancer
por: Hartnett, Erin G., et al.
Publicado: (2020)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003)

Chemokine Receptors in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2013)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

The BRCA Gene in Epithelial Ovarian Cancer
por: Sánchez-Lorenzo, Luisa, et al.
Publicado: (2022)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

Pathophysiology and management of classic galactosemic primary ovarian insufficiency
por: Hagen-Lillevik, Synneva, et al.
Publicado: (2021)

Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma
por: Casagrande, Naike, et al.
Publicado: (2022)

Targeted Therapies in Epithelial Ovarian Cancer
por: Barrena Medel, Nicanor I., et al.
Publicado: (2010)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Ovarian Epithelial Cancer Stem Cells
por: Conic, Irena, et al.
Publicado: (2011)

Clinical epidemiology of epithelial ovarian cancer in the UK
por: Doufekas, Konstantinos, et al.
Publicado: (2014)

Targeting Signaling Pathways in Epithelial Ovarian Cancer
por: Smolle, Elisabeth, et al.
Publicado: (2013)

The role of surgery in advanced epithelial ovarian cancer
por: Martín-Cameán, María, et al.
Publicado: (2016)

Microbial infection, inflammation and epithelial ovarian cancer
por: Xie, Xiaohui, et al.
Publicado: (2017)

Tumor metabolism rewiring in epithelial ovarian cancer
por: Wang, Ming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9pjuc8635kie5m7g2c2106h45i